Pancreatic Cancer Research

ResearcherBoston UniversityNo recent work listed

Christopher Marr Gromisch

ORCID-verified (high confidence)As of 10 November 2026

Matched on ORCID iD 0000-0002-2927-7228; OpenAlex author ID A5065666319; NIH RePORTER profile ID 14339660.

Their work

Papers
2 (first author 2, last author 0)
Trials
0
Grants
1
Collaborators
4
Papers, trials and grants by year

2020: 1 paper, 1 grant · 2021: 1 paper

Papers 2

  1. Humanized anti-DEspR IgG4S228P antibody increases overall survival in a pancreatic cancer stem cell-xenograft peritoneal carcinomatosis rat nu/nu model. First author DOI 10.1186/s12885-021-08107-w↗
  2. Pancreatic Adenocarcinoma: Unconventional Approaches for an Unconventional Disease. First author DOI 10.1158/0008-5472.can-19-2731↗

Grants 1

  1. Development of a novel Antibody Drug Conjugate for the treatment of pancreaticcancer F30CA220843↗

Closest collaborators

The 4 strongest of 4 ranked by shared papers, trials and grants, with recent and small-team work weighing most.

  1. Mark W. Grinstaff · 2 shared papers, 2020–2021
  2. Kebin Liu · 1 shared paper, 2020
  3. Motaz Qadan · 1 shared paper, 2020
  4. Nelson Ruiz-Opazo · 1 shared paper, 2021

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (the fewest links first, then the links with the most shared work). Built from public records only; no contact details are kept.